American Portfolios Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$170K Sell
691
-83
-11% -$22.4K 0.01% 1083
2022
Q2
$192K Sell
774
-154
-17% -$41.6K 0.01% 1062
2022
Q1
$307K Buy
928
+245
+36% +$75.4K 0.01% 962
2021
Q4
$245K Sell
683
-67
-9% -$22.6K 0.01% 1044
2021
Q3
$244K Buy
750
+65
+9% +$22K 0.01% 1026
2021
Q2
$214K Hold
685
0.01% 1074
2021
Q1
$218K Buy
685
+20
+3% +$6.4K 0.01% 984
2020
Q4
$216K Buy
665
+55
+9% +$15.2K 0.01% 860
2020
Q3
$169K Sell
610
-89
-13% -$25.6K 0.01% 863
2020
Q2
$169K Sell
699
-1,012
-59% -$203K 0.01% 796
2020
Q1
$248K Buy
1,711
+67
+4% +$11.1K 0.02% 581
2019
Q4
$280K Buy
1,644
+1,060
+182% +$197K 0.02% 621
2019
Q3
$104K Buy
584
+77
+15% +$16.6K 0.01% 980
2019
Q2
$132K Buy
507
+132
+35% +$35K 0.01% 874
2019
Q1
$107K Buy
375
+109
+41% +$36.2K 0.01% 862
2018
Q4
$86.5K Sell
266
-149
-36% -$51.8K 0.01% 786
2018
Q3
$187K Sell
415
-23
-5% -$9.07K 0.02% 609
2018
Q2
$179K Buy
438
+73
+20% +$26.4K 0.02% 594
2018
Q1
$106K Sell
365
-217
-37% -$55K 0.02% 730
2017
Q4
$109K Buy
+582
New +$109K 0.02% 701

Other funds holding ABMD

American Portfolios Advisors's ABMD Position: Q3 2022 in Review

American Portfolios Advisors reduced its Abiomed Inc (ABMD) stake by 11% in Q3 2022, selling an estimated $22.4K and leaving 691 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #1083.

American Portfolios Advisors first reported a position in ABMD in Q4 2017 and has held it in 20 quarters since. The position peaked at $307K in Q1 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • American Portfolios Advisors held 691 shares of Abiomed Inc worth $170K as of Q3 2022.
  • American Portfolios Advisors sold 83 Abiomed Inc shares in Q3 2022, an estimated $22.4K.
  • Abiomed Inc made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1083 holding.
  • American Portfolios Advisors first reported a position in Abiomed Inc in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Abiomed Inc position peaked at $307K in Q1 2022.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.